This is the authors' abstract. We don't add key points for this paper.
Background High-fat diet (HFD) is known to promote periodontitis progression via gut microbial imbalance. However, the redox-related molecular events linking these processes have yet to be fully elucidated. We propose that the gut microbiota, trimethylamine N-oxide (TMAO) and macrophage polarisation cascade constitute a pivotal pathway through which HFD aggravates periodontal destruction, and we further assess the efficacy of a gut-retentive genistein-loaded zein/fucoidan nanoparticle (G@Z/F) as an intervention. Methods A ligature-induced periodontitis model was established in C57BL/6 mice fed normal or HFD. Gut microbiota was analysed by 16S rRNA sequencing, and circulating TMAO levels were quantified using liquid chromatography tandem mass spectrometry (LC-MS/MS). Macrophage polarisation and signalling changes were evaluated by immunofluorescence, Western blot, and qPCR in vivo and in vitro. G@Z/F nanoparticles were prepared via anti-solvent precipitation and characterised for their physicochemical properties, stability and intestinal retention capability. Therapeutic efficacy against HFD-associated periodontitis was assessed by micro-CT, histological staining and molecular assays, with mechanistic validation using antibiotic depletion (ABX) and fecal microbiota transplantation (FMT). Results HFD feeding led to expansion of TMA-generating bacterial taxa and a rise in systemic TMAO. TMAO suppressed nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) antioxidant axis while activating nuclear factor kappa B (NF-κB), skewing macrophages toward M1, amplifying oxidative stress and aggravating alveolar bone resorption. G@Z/F administration reestablished eubiosis, lowered TMAO and improved intestinal barrier function. Mechanistically, G@Z/F shifted M1/M2 balance via upregulating Nrf2/HO-1 and inhibiting NF-κB. Both ABX and FMT confirmed therapeutic benefits were dependent on gut microbiota. Conclusions Collectively, four findings lend support to the notion that the gut-TMAO-macrophage axis could serve as an important contributing mediator in diet-exacerbated periodontitis. G@Z/F emerges as a promising gut-retentive nanotherapeutic agent capable of counteracting periodontal inflammation by modulating redox-sensitive signalling pathways and restoring gut microbiome homeostasis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: